Investigational Drug Information for Tricaprilin
✉ Email this page to a colleague
What is the drug development status for Tricaprilin?
Tricaprilin is an investigational drug.
There have been 14 clinical trials for Tricaprilin.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 30th 2022.
The most common disease conditions in clinical trials are Alzheimer Disease, Spasm, and Migraine Disorders. The leading clinical trial sponsors are Cerecin, Accera, Inc., and [disabled in preview].
There are two hundred and seventy-three US patents protecting this investigational drug and zero international patents.
Summary for Tricaprilin
| US Patents | 273 |
| International Patents | 8,470 |
| US Patent Applications | 2,920 |
| WIPO Patent Applications | 2,075 |
| Japanese Patent Applications | 1,874 |
| Clinical Trial Progress | Phase 2 (2022-06-30) |
| Vendors | 53 |
Recent Clinical Trials for Tricaprilin
| Title | Sponsor | Phase |
|---|---|---|
| Tricaprilin Phase 3 AD Study | Cerecin | Phase 3 |
| AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions | Cerecin | Phase 1 |
| A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects | Cerecin | Phase 1 |
Clinical Trial Summary for Tricaprilin
Top disease conditions for Tricaprilin
Top clinical trial sponsors for Tricaprilin
US Patents for Tricaprilin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tricaprilin | ⤷ Sign Up | Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse | Acura Pharmaceuticals, Inc. (Palatine, IL) | ⤷ Sign Up |
| Tricaprilin | ⤷ Sign Up | Dosing regimens for echinocandin class compounds | Cidara Therapeutics, Inc. (San Diego, CA) | ⤷ Sign Up |
| Tricaprilin | ⤷ Sign Up | Engineered nucleic acids and methods of use thereof | ModernaTX, Inc. (Cambridge, MA) | ⤷ Sign Up |
| Tricaprilin | ⤷ Sign Up | Anthelmintic compounds | MERIAL INC. (Duluth, GA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tricaprilin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tricaprilin | World Intellectual Property Organization (WIPO) | WO2014063054 | 2032-10-19 | ⤷ Sign Up |
| Tricaprilin | World Intellectual Property Organization (WIPO) | WO2017083117 | 2035-11-10 | ⤷ Sign Up |
| Tricaprilin | World Intellectual Property Organization (WIPO) | WO2017083118 | 2035-11-10 | ⤷ Sign Up |
| Tricaprilin | Australia | AU2015274936 | 2034-06-09 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
